HomePASG • NASDAQ
Passage Bio Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.33M | -39.00% |
Net income | -9.39M | 41.31% |
Net profit margin | — | — |
Earnings per share | -2.96 | 43.08% |
EBITDA | -10.17M | 37.03% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 57.63M | -37.21% |
Total assets | 79.20M | -36.84% |
Total liabilities | 40.94M | 17.53% |
Total equity | 38.26M | — |
Shares outstanding | 3.18M | — |
Price to book | 0.63 | — |
Return on assets | -31.28% | — |
Return on capital | -38.33% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.39M | 41.31% |
Cash from operations | -6.33M | 51.81% |
Cash from investing | 585.00K | -44.18% |
Cash from financing | 14.00K | -83.53% |
Net change in cash | -5.73M | 52.25% |
Free cash flow | -2.72M | 66.67% |
Previous close
$7.54
Day range
$7.32 - $7.71
Year range
$5.12 - $26.60
Market cap
23.55M USD
Avg Volume
35.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Headquarters
Website
Employees
60
